Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial

CSPS.com Trial Investigators

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)

Fingerprint Dive into the research topics of 'Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences